Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and mitochondrial complexes expression

Journal of Cellular Biochemistry

Volumn 114, Issue 12, 2013, Pages 2785-2794

  Blanquer Rossellõ, M Mar ^a,b   Oliver, Jordi ^a,b   Valle, Adamo ^a,b   Roca, Pilar ^a,b  

^a Institut Universitari d'Investigacio en Ciencies de la Salut IUNICS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

8 PRENYLNARINGENIN; BREAST CANCER; MCF 7; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION SYSTEM; OXIDATIVE STRESS; SIRTUINS; XANTHOHUMOL

Indexed keywords

8 PRENYLNARINGENIN; CATALASE; GLUTATHIONE REDUCTASE; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 3; SUPEROXIDE DISMUTASE; XANTHOHUMOL;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; BREAST CANCER; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMULUS LUPULUS; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

8-PRENYLNARINGENIN; BREAST CANCER; MCF-7; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION SYSTEM; OXIDATIVE STRESS; SIRTUINS; XANTHOHUMOL;

BREAST NEOPLASMS; CATALASE; CELL SURVIVAL; ELECTRON TRANSPORT COMPLEX I; FEMALE; FLAVANONES; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE REDUCTASE; HUMANS; MCF-7 CELLS; MITOCHONDRIA; OXIDATIVE STRESS; PROPIOPHENONES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84885639233     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24627     Document Type: Article

References (51)

1. Antosiewicz J, Ziolkowski W, Kar S, Powolny AA, Singh SV,. 2008. Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Med 74: 1570-1579.
2. Bause AS, Haigis MC,. 2012. SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol.
3. Bell EL, Emerling BM, Ricoult SJ, Guarente L,. 2011. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30: 2986-2996.
4. Bolca S, Li J, Nikolic D, Roche N, Blondeel P, Possemiers S, De Keukeleire D, Bracke M, Heyerick A, van Breemen RB, Depypere H,. 2010. Disposition of hop prenylflavonoids in human breast tissue. Mol Nutr Food Res 54 (Suppl 2): S284-S294.
5. Brunelli E, Pinton G, Chianale F, Graziani A, Appendino G, Moro L,. 2009. 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. J Steroid Biochem Mol Biol 113: 163-170.
6. Carlberg I, Mannervik B,. 1985. Glutathione reductase. Methods Enzymol 113: 484-490.
7. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E,. 2007. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246: 201-209.
8. Deeb D, Gao X, Jiang H, Arbab AS, Dulchavsky SA, Gautam SC,. 2010. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. Anticancer Res 30: 3333-3339.
9. Delmulle L, Bellahcene A, Dhooge W, Comhaire F, Roelens F, Huvaere K, Heyerick A, Castronovo V, De Keukeleire D,. 2006. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13: 732-734.
10. Dorn C, Weiss TS, Heilmann J, Hellerbrand C,. 2010. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. Int J Oncol 36: 435-441.
11. Drenzek JG, Seiler NL, Jaskula-Sztul R, Rausch MM, Rose SL,. 2011. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecol Oncol 122: 396-401.
12. Festa M, Capasso A, D'Acunto CW, Masullo M, Rossi AG, Pizza C, Piacente S,. 2011. Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways. J Nat Prod 74: 2505-2513.
13. Finkel T, Deng CX, Mostoslavsky R,. 2009. Recent progress in the biology and physiology of sirtuins. Nature 460: 587-591.
14. Finley LW, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP, Haigis MC,. 2011. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 6: e23295.
15. Gerhauser C,. 2005. Beer constituents as potential cancer chemopreventive agents. Eur J Cancer 41: 1941-1954.
16. Giralt A, Villarroya F,. 2012. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444: 1-10.
17. Haigis MC, Guarente LP,. 2006. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921.
18. Hallows WC, Albaugh BN, Denu JM,. 2008. Where in the cell is SIRT3?-functional localization of an NAD+ -dependent protein deacetylase. Biochem J 411: e11-e13.
19. Ho YC, Liu CH, Chen CN, Duan KJ, Lin MT,. 2008. Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother Res 22: 1465-1468.
20. Jacob C, Jamier V, Ba LA,. 2011. Redox active secondary metabolites. Curr Opin Chem Biol 15: 149-155.
21. Johansson LH, Borg LA,. 1988. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174: 331-336.
22. Khan N, Afaq F, Mukhtar H,. 2008. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10: 475-510.
23. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R,. 2008. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123: 552-560.
24. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F, Chang Y,. 2010. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 5: e11707.
25. Lee KW, Lee HJ,. 2006. The roles of polyphenols in cancer chemoprevention. Biofactors 26: 105-121.
26. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Jr., Weissman S, Verdin E, Schwer B,. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27: 8807-8814.
27. Lust S, Vanhoecke B, Janssens A, Philippe J, Bracke M, Offner F,. 2005. Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Mol Nutr Food Res 49: 844-850.
28. Matsumura A, Ghosh A, Pope GS, Darbre PD,. 2005. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94: 431-443.
29. Menzies KJ, Hood DA,. 2012. The role of SirT1 in muscle mitochondrial turnover. Mitochondrion 12: 5-13.
30. Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW, Buhler DR,. 1999. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 37: 271-285.
31. Miro AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J,. 2011. 17beta-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 123: 133-139.
32. Monteiro R, Faria A, Azevedo I, Calhau C,. 2007. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol 105: 124-130.
33. Monteiro R, Calhau C, Silva AO, Pinheiro-Silva S, Guerreiro S, Gartner F, Azevedo I, Soares R,. 2008. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 104: 1699-1707.
34. Pan L, Becker H, Gerhauser C,. 2005. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res 49: 837-843.
35. Park SH, Ozden O, Jiang H, Cha YI, Pennington JD, Aykin-Burns N, Spitz DR, Gius D, Kim HS,. 2011. Sirt3, mitochondrial ROS, ageing, and carcinogenesis. Int J Mol Sci 12: 6226-6239.
36. Quick KL, Hardt JI, Dugan LL,. 2000. Rapid microplate assay for superoxide scavenging efficiency. J Neurosci Methods 97: 139-144.
37. Rasbach KA, Schnellmann RG,. 2008. Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 325: 536-543.
38. Shahbazian MD, Grunstein M,. 2007. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76: 75-100.
39. Shakibaei M, Shayan P, Busch F, Aldinger C, Buhrmann C, Lueders C, Mobasheri A,. 2012. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation. PLoS ONE 7: e35712.
40. Signorelli P, Ghidoni R,. 2005. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16: 449-466.
41. Stevens JF, Page JE,. 2004. Xanthohumol and related prenylflavonoids from hops and beer: to your good health ! Phytochemistry 65: 1317-1330.
42. Strathmann J, Klimo K, Sauer SW, Okun JG, Prehn JH, Gerhauser C,. 2010. Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism. FASEB J 24: 2938-2950.
43. Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W,. 2009. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 11: 1-13.
44. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P,. 2006. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10: 241-252.
45. Trachootham D, Alexandre J, Huang P,. 2009. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach ? Nat Rev Drug Discov 8: 579-591.
46. Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML, Yen ML,. 2011. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res 26: 2552-2563.
47. Vanhoecke B, Derycke L, Van Marck V, Depypere H, De Keukeleire D, Bracke M,. 2005. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int J Cancer 117: 889-895.
48. Yang JY, Della-Fera MA, Rayalam S, Baile CA,. 2007. Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 12: 1953-1963.
49. Yu W, Dittenhafer-Reed KE, Denu JM,. 2012. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287: 14078-14086.
50. Zajc I, Filipic M, Lah TT,. 2012. Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and normal astrocytes. Phytother Res 26: 1709-1713.
51. Zanoli P, Zavatti M,. 2008. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol 116: 383-396.